Delivery Order SPE2DB22D9316-SPE2DB24FYM51
Award Date
11/1/23
Potential Completion Date
11/24/23
Potential Value
$9.6K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $57,747.24 by the Defense Logistics Agency to provide 4562852686 units of Entyvio 300 mg vials. The delivery order was awarded on November 15, 2023 under DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a total potential value of up to $5 million through December 2025. As a woman-owned small business and...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $48,122.70 by the Defense Logistics Agency to provide 4562986926 units of Entyvio 300 mg vials. The delivery order was awarded on November 30, 2023 under DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. As a woman-owned small business and pharmaceutical...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide 4562945987 units of Entyvio 300 mg vials. The $48,122.70 order has a completion date of December 18, 2023 and was awarded on November 27, 2023. DMS Pharmaceutical Group is a woman-owned small business and woman-owned business located in Park Ridge, Illinois that holds numerous contracts to supply pharmaceutical and medical products...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide 4562966584 units of Entyvio 300 mg vials. The $19,249.08 order has a completion date of December 14, 2023 and was awarded on November 22, 2023. DMS Pharmaceutical Group holds this indefinite delivery contract with the Defense Logistics Agency, valued at up to $5 million through December 2025, to supply pharmaceutical items and...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $28,873.62 by the Defense Logistics Agency to provide 4563079612 ENTYVIO 300 MG VIALS. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceutical items and medical products with a potential value of up to $5 million through December 2025. As a woman-owned small business and pharmaceutical wholesaler, DMS...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at one hundred forty-four thousand three hundred sixty-seven dollars and eighty cents ($144,367.80) by the Defense Logistics Agency. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract to supply pharmaceutical items and medical products to support military treatment facilities worldwide. Under this particular award, DMS Pharmaceutical Group will provide forty-five...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at twenty-four thousand sixty-one dollars and thirty cents ($24,061.30) by the Defense Logistics Agency to provide Entyvio 300 mg vials. The delivery order was issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group with the Defense Logistics Agency for pharmaceutical supplies with a potential value of up to five million dollars through December 2025. No set-aside...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical pharmaceutical prime vendor contract to provide 4562661629 ENTYVIO 300 MG VIALS with a potential value of $14,436.78. The delivery order has a completion date of November 17, 2023 and was awarded on October 26, 2023 without a set-aside designation. As a woman-owned small business and woman-owned business, DMS Pharmaceutical Group will supply the Entyvio...
The U.S. Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Entyvio 300 mg vials. The $39,429.44 award has a completion date of January 30, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts to supply pharmaceuticals and medical products to the Department of Defense. This delivery order is issued against DMS Pharmaceutical Group's existing...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $19,249.08 by the Defense Logistics Agency to provide 4562850265 ENTYVIO 300 MG VIALS. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. No set-aside designation was used for this award. DMS Pharmaceutical...